Gene expression analysis of purified hematopoietic stem cells and committed progenitors

Blood

Volumn 102, Issue 1, 2003, Pages 94-101

  Terskikh, Alexey V ^a   Miyamoto, Toshihiro ^b   Chang, Cynthia ^b   Diatchenko, Luda ^b   Weissman, Irving L ^b  

^a EPFL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; DNA MICROARRAY; ERYTHROCYTE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNOREGULATION; LYMPHOID CELL; MEGAKARYOCYTE; METABOLISM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROLYMPHOCYTE; PROMYELOCYTE; STEM CELL; T LYMPHOCYTE; UNINDEXED SEQUENCE;

EID: 0037968549     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-08-2509     Document Type: Article

References (46)

1. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000;100:157-168.
2. Gage FH. Mammalian neural stem cells. Science. 2000;287:1433-1438.
3. Watt FM, Hogan BL. Out of Eden: stem cells and their niches. Science. 2000;287:1427-1430.
4. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science. 1988;241:58-62.
5. Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1994;1:661-673.
6. Phillips RL, Ernst RE, Brunk B, et al. The genetic program of hematopoietic stem cells. Science. 2000;288:1635-1640.
7. Terskikh A, Easterday M, Li L, et al. From hematopoiesis to neuropoiesis: evidence of ovelapping genetic program. Proc Natl Acad Sci U S A. 2001;98:7934-7939.
8. Kondo M, Weissman IL, Akashi K. Identification of c(onogenic common (ymphoid progenitors in mouse bone marrow. Cell. 1997;91:661-672.
9. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404:193-197.
10. Kondo M, Scherer DC, Miyamoto T, et al. Cellfate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 2000;407:383-386.
11. Miyamoto T, Iwasaki H, Reizis B, et al. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev Cell. 2002;3:137-147.
12. Livesey FJ, Furukawa T, Steffen MA, Church GM, Cepko CL. Microarray analysis of the transcriptional network controlled by the photoreceptor homeobox gene Crx. Curr Biol. 2000;10:301-310.
13. Na Nakom T, Traver D, Weissman IL, Akashi N. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest. 2002;109:1579-1585.
14. Sudo T, Nishikawa S, Ohno N, et al. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci U S A. 1993;90:9125-9129.
15. Reya T, O'Riordan M, Okamura R, et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity. 2000;13:15-24.
16. Wagers AJ, Allsopp RC, Weissman IL. Changes in integrin expression are associated with altered homing properties of Lin(-/lo)Thy1.1(lo) Sca-1(+)c-kit(+) hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp Hematol. 2002;30:176-185.
17. Murray LJ, Young JC, Osborne LJ, Luens KM, Scollay R, Hill BL. Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1+ cells into rapid division. Exp Hematol. 1999;27:1019-1028.
18. Kusadasi N, van Soest PL, Mayen AE, Koevoet JL, Ploemacher RE. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood. Leukemia. 2000;14:1944-1953.
19. Ema H, Takano H, Sudo K, Nakauchi H. In vitro self-renewal division of hematopoietic stem cells. J Exp Med. 2000;192:1281-1288.
20. Domen J, Weissman IL, Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J Exp Med. 2000;192:1707-1718.
21. Kimura S, Roberts AW, Metcalf D, Alexander WS. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci U S A. 1998;95:1195-1200.
22. Takakura N, Watanabe T, Suenobu S, et al. A role for hematopoietic stem cells in promoting angiogenesis. Cell. 2000;102:199-209.
23. Sato A, Iwama A, Takakura N, Nishio H, Yancopoulos GD, Suda T. Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells. Int Immunol. 1998;10:1217-1227.
24. Takakura N, Huang XL, Naruse T, et al. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity. 1998;9:677-686.
25. Suda T, Takakura N, Oike Y. Hematopoiesis and angiogenesis. Int J Hematol. 2000;71:99-107.
26. Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood. 1992;80:2735-2739.
27. Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell. 1991;66:85-94.
28. McCoy C, Smith DE, Cornwell MM. 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol Cell Biol. 1995;15:6100-6108.
29. Harada T, Morooka T, Ogawa S, Nishida E. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol. 2001;3:453-459.
30. Xu PX, Adams J, Peters H, Brown MC, Heaney S, Maas R. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet. 1999;23:113-117.
31. Oike Y, Takakura N, Hata A, et al. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculoangiogenesis. Blood. 1999;93:2771-2779.
32. Hai T, Hartman MG. The molecular biology and nomendature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene. 2001;273:1-11.
33. Wang YK, Perez-Jurado LA, Francke U. A mouse single-copy gene, Gtf2i, the homolog of human GTF21, that is duplicated in the Williams-Beuren syndrome deletion region. Genomics. 1998;48:163-170.
34. Lawrence HJ, Helgason CD, Sauvageau G, et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood. 1997;89:1922-1930.
35. Schnabel CA, Jacobs Y, Cleary ML. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene. 2000;19:608-616.
36. Reya T, Morrison SJ, Clarke M, Weissman IL. Stem cells, cancer, cancer stem cells. Nature. 2001;414:105-111.
37. Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1:489-495.
38. Zhou P, Levy NB, Xie H, et al. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood. 2001;97:3902-3909.
39. Zhou P, Qian L, Bieszczad CK, et al, Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage. Blood. 1998;92:3226-3239.
40. Fujise K, Zhang D, Liu J, Yeh ET. Regulation of apoptosis and cell cycle progression by MCL1: differential role of proliferating cell nuclear antigen. J Biol Chem. 2000;275:39458-39465.
41. Hamilton JA. CSF-1 signal transduction. J Leukoc Biol. 1997;62:145-155.
42. Takamatsu S, Nakano K. Histamine synthesis by cells of the macrophage lineage in bone marrow of mice. Biosci Biotechnol Biochem. 1995;59:1493-1497.
43. Laszlo V, Rothe G, Hegyesi H, et al. Increased histidine decarboxylase expression during in vitro monocyte maturation; a possible role of endogenously synthesised histamine in monocyte/macrophage differentiation. Inflamm Res. 2001;50:428-434.
44. Morgan RO, Naglie G, Horrobin DF, Barbeau A. Erythrocyte protoporphyrin levels in patients with Friedreich's and other ataxias. Can J Neurol Sci. 1979;6:227-232.
45. Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrpl/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001;7:1028-1034.
46. Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med. 2001;193:1005-1014.